115 related articles for article (PubMed ID: 11012030)
1. Enhanced pneumocystis carinii activity of new primaquine analogues.
Goodwin TE; Boylan CJ; Current WL; Byrd JC; Edwards CB; Fuller DA; Green JL; Larocca CD; Raney KD; Ross AS; Tucker WA
Bioorg Med Chem Lett; 2000 Oct; 10(19):2205-8. PubMed ID: 11012030
[TBL] [Abstract][Full Text] [Related]
2. Anti-Pneumocystis carinii and antiplasmodial activities of primaquine-derived imidazolidin-4-ones.
Vale N; Collins MS; Gut J; Ferraz R; Rosenthal PJ; Cushion MT; Moreira R; Gomes P
Bioorg Med Chem Lett; 2008 Jan; 18(2):485-8. PubMed ID: 18077165
[TBL] [Abstract][Full Text] [Related]
3. Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.
Porollo A; Meller J; Joshi Y; Jaiswal V; Smulian AG; Cushion MT
Curr Drug Targets; 2012 Nov; 13(12):1575-85. PubMed ID: 22934582
[TBL] [Abstract][Full Text] [Related]
4. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.
Queener SF; Bartlett MS; Richardson JD; Durkin MM; Jay MA; Smith JW
Antimicrob Agents Chemother; 1988 Jun; 32(6):807-13. PubMed ID: 3261959
[TBL] [Abstract][Full Text] [Related]
5. Dicationic diarylfurans as anti-Pneumocystis carinii agents.
Boykin DW; Kumar A; Spychala J; Zhou M; Lombardy RJ; Wilson WD; Dykstra CC; Jones SK; Hall JE; Tidwell RR
J Med Chem; 1995 Mar; 38(6):912-6. PubMed ID: 7699707
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.
Jimenez E; Martínez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D
Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948
[TBL] [Abstract][Full Text] [Related]
7. Are cytochrome b gene mutations the only cause of atovaquone resistance in Pneumocystis?
Kaneshiro ES
Drug Resist Updat; 2001 Oct; 4(5):322-9. PubMed ID: 11991686
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of severe pneumocystis pneumonia with clindamycin-primaquine in an HIV-negative patient.
Crisp HC; Stewart IJ; Blatz PJ; Rice DH; Okulicz JF
South Med J; 2009 Nov; 102(11):1161-3. PubMed ID: 19864989
[TBL] [Abstract][Full Text] [Related]
9. 4-substituted 5-[m-(trifluoromethyl)phenoxy]primaquine analogues as potential antimalarial agents.
Carroll FI; Berrang B; Linn CP
J Med Chem; 1985 Nov; 28(11):1564-7. PubMed ID: 4067985
[TBL] [Abstract][Full Text] [Related]
10. Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.
Hall JE; Kerrigan JE; Ramachandran K; Bender BC; Stanko JP; Jones SK; Patrick DA; Tidwell RR
Antimicrob Agents Chemother; 1998 Mar; 42(3):666-74. PubMed ID: 9517949
[TBL] [Abstract][Full Text] [Related]
11. Studies of the susceptibility of Pneumocystis carinii to clindamycin/primaquine in rats.
Smith JW
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):201-3. PubMed ID: 2060531
[TBL] [Abstract][Full Text] [Related]
12. Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii.
Ball MD; Bartlett MS; Shaw M; Smith JW; Nasr M; Meshnick SR
Antimicrob Agents Chemother; 2001 May; 45(5):1473-9. PubMed ID: 11302813
[TBL] [Abstract][Full Text] [Related]
13. Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Pavić K; Perković I; Pospíšilová Š; Machado M; Fontinha D; Prudêncio M; Jampilek J; Coffey A; Endersen L; Rimac H; Zorc B
Eur J Med Chem; 2018 Jan; 143():769-779. PubMed ID: 29220797
[TBL] [Abstract][Full Text] [Related]
14. Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii.
Goheen MP; Bartlett MS; Shaw MM; Queener SF; Smith JW
Int J Exp Pathol; 1993 Aug; 74(4):379-87. PubMed ID: 8398811
[TBL] [Abstract][Full Text] [Related]
15. Atypical Pneumocystis carinii infection in AIDS: massive cervical lymphadenitis and fever of unknown origin.
Kallen AJ; Wallace MR
South Med J; 1998 Aug; 91(8):759-60. PubMed ID: 9715224
[TBL] [Abstract][Full Text] [Related]
16. The effect of primaquine on the ultrastructural morphology of Pneumocystis carinii.
Goheen MP; Bartlett MS; Queener SF; Smith JW
J Protozool; 1991; 38(6):164S-165S. PubMed ID: 1818151
[TBL] [Abstract][Full Text] [Related]
17. 4,5-Disubstituted primaquine analogues as potential antimalarial agents.
Carroll FI; Berrang BD; Linn CP
J Med Chem; 1986 Sep; 29(9):1796-8. PubMed ID: 3746825
[TBL] [Abstract][Full Text] [Related]
18. Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.
Pavić K; Perković I; Cindrić M; Pranjić M; Martin-Kleiner I; Kralj M; Schols D; Hadjipavlou-Litina D; Katsori AM; Zorc B
Eur J Med Chem; 2014 Oct; 86():502-14. PubMed ID: 25203780
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
Rosowsky A; Papoulis AT; Forsch RA; Queener SF
J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of primaquine analogues and their antimalarial activity in mice].
Jiang Q; Zhong J; Shi Y; Li G
Yao Xue Xue Bao; 1998; 33(3):194-200. PubMed ID: 11938965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
